Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor angiogenesis is the formation of new blood vessels from pre-existing vasculature to supply nutrients and oxygen to tumors, enabling their growth and metastasis. This process is driven by pro-angiogenic factors released by tumor cells and surrounding host cells, stimulating endothelial cell proliferation, migration, and differentiation. It is essential for sustained tumor growth, metabolic support, waste removal, and facilitates metastasis. While targeting angiogenesis is a major therapeutic strategy, challenges remain due to tumor heterogeneity and adaptive resistance mechanisms.
Inhibition of VEGF signaling, blockade of endothelial cell proliferation and migration
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Angiogenesis (None).